These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 38394222)
1. Novel Drug Delivery Systems for the Management of Fungal Keratitis. Ruan M; Wang R; He Y J Ocul Pharmacol Ther; 2024 Apr; 40(3):160-172. PubMed ID: 38394222 [TBL] [Abstract][Full Text] [Related]
2. Recent advances in nanotechnology for the treatment of fungal keratitis. Zhang F; Zhang J; Zhang W Eur J Ophthalmol; 2024 Jan; 34(1):18-29. PubMed ID: 37198915 [TBL] [Abstract][Full Text] [Related]
3. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization. Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672 [TBL] [Abstract][Full Text] [Related]
4. Biophilic Positive Carbon Dot Exerts Antifungal Activity and Augments Corneal Permeation for Fungal Keratitis. Chen H; Geng X; Ning Q; Shi L; Zhang N; He S; Zhao M; Zhang J; Li Z; Shi J; Li J Nano Lett; 2024 Apr; 24(13):4044-4053. PubMed ID: 38517749 [TBL] [Abstract][Full Text] [Related]
5. Contact lenses for antifungal ocular drug delivery: a review. Phan CM; Subbaraman L; Jones L Expert Opin Drug Deliv; 2014 Apr; 11(4):537-46. PubMed ID: 24472171 [TBL] [Abstract][Full Text] [Related]
6. Solid Dispersion Incorporated into Dissolving Microneedles for Improved Antifungal Activity of Amphotericin B: Mahfud MAS; Syahirah NA; Akram M; Mahfufah U; Saputra MD; Elim D; Andi MNF; Sultan NAF; Himawan A; Domínguez-Robles J; Pamornpathomkul B; Mir M; Permana AD Mol Pharm; 2023 Dec; 20(12):6246-6261. PubMed ID: 37975721 [TBL] [Abstract][Full Text] [Related]
7. The preparation and therapeutic effects of β-glucan-specific nanobodies and nanobody-natamycin conjugates in fungal keratitis. Liu X; Sui J; Li C; Wang Q; Peng X; Meng F; Xu Q; Jiang N; Zhao G; Lin J Acta Biomater; 2023 Oct; 169():398-409. PubMed ID: 37579912 [TBL] [Abstract][Full Text] [Related]
8. Fabrication of a drug delivery system that enhances antifungal drug corneal penetration. Li J; Li Z; Liang Z; Han L; Feng H; He S; Zhang J Drug Deliv; 2018 Nov; 25(1):938-949. PubMed ID: 29658325 [TBL] [Abstract][Full Text] [Related]
10. A Rapid Corneal Healing Microneedle for Efficient Ocular Drug Delivery. Shi H; Zhou J; Wang Y; Zhu Y; Lin D; Lei L; Vakal S; Wang J; Li X Small; 2022 Jan; 18(4):e2104657. PubMed ID: 35083856 [TBL] [Abstract][Full Text] [Related]
12. Natamycin Ocular Delivery: Challenges and Advancements in Ocular Therapeutics. Mascarenhas M; Chaudhari P; Lewis SA Adv Ther; 2023 Aug; 40(8):3332-3359. PubMed ID: 37289410 [TBL] [Abstract][Full Text] [Related]
13. Update on the management of fungal keratitis. Sha XY; Shi Q; Liu L; Zhong JX Int Ophthalmol; 2021 Sep; 41(9):3249-3256. PubMed ID: 33929644 [TBL] [Abstract][Full Text] [Related]
14. Zero order delivery of itraconazole via polymeric micelles incorporated in situ ocular gel for the management of fungal keratitis. Jaiswal M; Kumar M; Pathak K Colloids Surf B Biointerfaces; 2015 Jun; 130():23-30. PubMed ID: 25889081 [TBL] [Abstract][Full Text] [Related]
15. Comparative study on costs incurred for treatment of patients with bacterial and fungal keratitis - A retrospective analysis. Radhakrishnan N; Pathak N; Subramanian KR; Das DR; Ningombam R; Khaitan I; Gandhi N; Rahul R; Prajna NV Indian J Ophthalmol; 2022 Apr; 70(4):1191-1195. PubMed ID: 35326013 [TBL] [Abstract][Full Text] [Related]
16. Clinical Investigation of the Safety and Efficacy of Low-temperature Plasma as an Adjuvant Treatment for Mild to Moderate Fungal Keratitis: A Pilot Study. Cheng J; Wei A; Hong J; Xu J Ocul Immunol Inflamm; 2023 Jul; 31(5):881-890. PubMed ID: 35522197 [TBL] [Abstract][Full Text] [Related]
17. Development of a Poly-ε-Lysine Contact Lens as a Drug Delivery Device for the Treatment of Fungal Keratitis. Gallagher AG; McLean K; Stewart RMK; Wellings DA; Allison HE; Williams RL Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4499-4505. PubMed ID: 28873175 [TBL] [Abstract][Full Text] [Related]
18. Drug-loaded mesoporous carbon with sustained drug release capacity and enhanced antifungal activity to treat fungal keratitis. Gu L; Li C; Lin J; Wang Q; Yin M; Zhang L; Li N; Lin H; You Z; Wang S; Li D; Zhao G Biomater Adv; 2022 May; 136():212771. PubMed ID: 35929310 [TBL] [Abstract][Full Text] [Related]
19. The clinical and microbiological features and outcomes of fungal keratitis over 9 years in Sydney, Australia. Watson SL; Cabrera-Aguas M; Keay L; Khoo P; McCall D; Lahra MM Mycoses; 2020 Jan; 63(1):43-51. PubMed ID: 31556179 [TBL] [Abstract][Full Text] [Related]
20. Challenging case of treating fungal keratitis. Ler D; Pidro A; Miokovic AP Rom J Ophthalmol; 2022; 66(1):69-74. PubMed ID: 35531444 [No Abstract] [Full Text] [Related] [Next] [New Search]